2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Neoplasms
1
Kidney Neoplasms
1
Glioblastoma
1
Coronary Artery Disease
1
Clear-cell metastatic renal cell carcinoma
1
Breast Neoplasms
1
Interventions
Nivolumab
14
Ipilimumab
11
Specimen Handling
10
CTLA-4 Antigen
7
pembrolizumab
6
cabozantinib
6
Sunitinib
6
Magnetic Resonance Spectroscopy
6
Axitinib
5
pazopanib
4
Biopsy
4
Radiosurgery
3
lenvatinib
2
fludarabine
2
Everolimus
2
Blood Specimen Collection
2
tivozanib
1
sodium-iodide symporter
1
sitravatinib
1
belzutifan
1
atezolizumab
1
aldesleukin
1
Zoledronic Acid
1
Tissue Banks
1
Selenomethionine
1
Radiotherapy
1
Radiopharmaceuticals
1
Pluvicto
1
Nephrectomy
1
Molecular Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Clear-cell metastatic renal cell carcinoma
×
Molecular Imaging
×
Clear all
NCT02228954
2021-12-07
IMPACT-RCC
Radboud University Medical Center
Completed
40 enrolled